The vitamin K2 market is projected to grow from $179.0 million in 2026 to $339.9 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Vitamin K2 demand is poised to grow steadily, backed by the rising consumer awareness regarding its benefits for bone and cardiovascular health, as well as healthy calcium metabolism.
Market Size and Forecast
The market size value in 2025 was $158.0 million, and in 2026 it was $179 million. The revenue forecast in 2031 is $339.9 million, with a growth rate of 13.7% from 2026 to 2031. The Asia Pacific region is projected to register the highest CAGR of 14.2% during the forecast period.
The health supplements segment is estimated to account for the largest market share of 80.9% in 2026. The natural segment is expected to exhibit the fastest growth rate during the forecast period, driven by increasing appreciation for plant-based, non-GMO, and sustainable nutritional products.
Leading Companies
The report profiles key players such as Gnosis by Lesaffre (France), Balchem Corp. (US), Novonesis A/S (Denmark), and Vesta Nutra (US). These companies are investing in advanced fermentation techniques to proliferate the quality and scale of products, while regulatory support and increasing confidence among consumers for naturally sourced ingredients are also favoring the growth of this segment.
Original reporting: KTBS 3 (Shreveport) — read the source article.
